Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
687

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.

Brain communications·2026
Same author

Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Factors influencing accelerated progression in behavioral variant frontotemporal dementia.

Journal of neurology·2026
Same author

Continuous At-Home Monitoring of Nighttime Bed Behavior in Frontotemporal Dementia.

Neurology open access·2026
Same author

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.

medRxiv : the preprint server for health sciences·2026
Same journal

Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer's Disease.

International journal of Alzheimer's disease·2024
Same journal

Advancements and Challenges in Antiamyloid Therapy for Alzheimer's Disease: A Comprehensive Review.

International journal of Alzheimer's disease·2024
Same journal

Novel Biomarkers for Alzheimer's Disease: Plasma Neurofilament Light and Cerebrospinal Fluid.

International journal of Alzheimer's disease·2024
Same journal

<i>In Silico</i> Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases.

International journal of Alzheimer's disease·2024
Same journal

Unveiling Neuroprotective Potential of Spice Plant-Derived Compounds against Alzheimer's Disease: Insights from Computational Studies.

International journal of Alzheimer's disease·2023
Same journal

Prognosis of Biomarker of Alzheimer's Disease in the Function of the Retina and Secondary Molecular Structure Variation of the Retina and Brain.

International journal of Alzheimer's disease·2023
See all related articles

Related Experiment Video

Updated: May 2, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K

Cost effective community based dementia screening: a markov model simulation.

Erin Saito1, Beau K Nakamoto2, Mario F Mendez3

  • 1Neurology Division, Los Angeles Biomedical Research Institute, 1124 West Carson Street, Torrance, CA 90502, USA.

International Journal of Alzheimer'S Disease
|March 21, 2014
PubMed
Summary
This summary is machine-generated.

Community dementia screening programs offer economic benefits by identifying individuals with mild cognitive impairment or dementia early. This early detection and intervention can reduce overall dementia care costs by 9.8% over ten years.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Related Experiment Videos

Last Updated: May 2, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Area of Science:

  • Gerontology
  • Public Health
  • Health Economics

Background:

  • The global dementia epidemic necessitates cost-effective healthcare strategies.
  • Rising healthcare expenditures highlight the need for economic assessments of dementia interventions.
  • Community-based dementia screening programs require evaluation for their financial impact.

Purpose of the Study:

  • To assess the economic benefits of community-based dementia screening.
  • To quantify the potential cost reductions in dementia care through early detection.
  • To model the long-term financial implications of dementia screening programs.

Main Methods:

  • Markov model simulations were employed to analyze costs over a 10-year period.
  • Data from a one-year community-based dementia screening program informed the model.
  • Simulations tracked patient costs based on clinical transitions from pre-dementia stages.

Main Results:

  • 93 individuals were screened; 12 met criteria for mild cognitive impairment (7) or dementia (5).
  • Early therapeutic intervention post-detection led to a simulated 9.8% reduction in dementia care costs over 10 years.
  • Cost savings were primarily achieved by prolonging mild stages and reducing time in severe, costly stages.

Conclusions:

  • Community-based dementia screening is a viable strategy for reducing healthcare costs.
  • Early diagnosis and treatment enable more efficient management of dementia care.
  • Interventions targeting earlier disease stages can significantly lower the economic burden of dementia.